AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Tamsulosin Hydrochloride in Nigeria
10 products registered with NAFDAC — 10 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Uwans Tamsulosin HCL USP 0.4 mg Capsules_ Capsule | B4-7056 | Uwans Ventures Limited | active | 28 Oct 2030 |
| Tamsulosin Hydrochloride 0.4 mg Capsules_ Capsule | A4-101366 | Embassy Pharmaceutical and Chemicals Limited | active | 24 Jun 2030 |
| Contixl Prolonged Release Capsule 400 mcg Capsule | A4-101203 | First J. Pocco Pharmacy Limited | active | 26 Mar 2030 |
| Tamcontin 0.4 mg Tablet Tablet | A4-101181 | Phillips Pharmaceuticals (Nigeria) Limited | active | 29 Jan 2030 |
| Glomaxtra-XL (dosage form) Tablet | C4-0175 | Global Healthcare Ltd | active | 29 Jan 2030 |
| Floezy Tablet** Prolonged-release tablet | A4-100938 | Mega Lifesciences Nigeria Limited | active | 30 Jul 2029 |
| Fiflo Capsules Capsule | A4-100550 | Sai Sagar Pharma Limited | active | 30 Oct 2028 |
| Strimax_ Capsule | A4-100356 | Evans Therapeutics Limited | active | 29 Mar 2028 |
| Flowel Capsule Capsule | B4-4365 | Superior Pharmaceuticals Limited | active | 25 Aug 2026 |
| Tamsuride Capsule Sustained Release Capsule | C4-1572 | Clarion Medicals Limited | active | 24 Feb 2026 |
Tamsulosin Hydrochloride — NAFDAC Registration Details
NAFDAC (Nigeria) has 10 registered products containing Tamsulosin Hydrochloride, of which 10 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Tamsulosin Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.